abstract |
PCT No. PCT/EP92/02704 Sec. 371 Date Jul. 15, 1994 Sec. 102(e) Date Jul. 15, 1994 PCT Filed Nov. 24, 1992 PCT Pub. No. WO93/10772 PCT Pub. Date Jun. 10, 1993The invention is represented by a transdermal medicated patch for the extended release of 17 beta -estradiol to the skin. The transdermal patch is formed by an outer covering, a matrix containing from 1% to 5% (w/w) 17 beta -estradiol, and a protective liner which is removed before use. The matrix is formed of pressure-sensitive adhesive acrylic copolymers, in which the active ingredient is dissolved or dispersed. The acrylic copolymers are obtained by radical copolymerization of 2-ethylhexyl acrylate, methyl acrylate, acrylic acid, vinyl acetate, hydroxyethyl acrylate or a mixture thereof. Optionally quantities of less than 0.5% (w/w) of other substances may be added. |